Covid 360 Panel

November 22, 2020, 3:00 pm - 4:30 pm

Add to iCal | Add to Google Calendar

REGISTER HERE and join Kol Shalom, Shaare Torah, and other community members for a “360” panel of leading scientists and pharma professionals to address the latest in the development and manufacturing of COVID vaccines as well as the virus’s effects on public health, mental health, pediatrics, immunocompromised individuals, and more.

Moderated by Shaare Torah Men’s Club Co-President Todd Haim, the COVID 360 Panel will address the most newsworthy COVID-related topics and help community members answer their most pressing questions.

Click here to join

The panel will answer frequently asked questions about the virus and vaccine development and will also answer participants’ questions during the event.
(Register at the link above to Pre-Submit your questions)

Panelists include:

Ilana Bar-Levav – President of Kol Shalom. She is board certified in internal medicine and has been practicing psychotherapy for individuals, couples and groups for almost 30 years. She will focus on how we each should be attending to our mental health as we get through this and can speak to community resources.

David Berlinger – Biopharma Professional with 25 years of vaccine manufacturing and process development experience, including 6 years at the Vaccine Research Center (NIAID, NIH), former Head of Viral Vaccine Manufacturing at the Pilot Bioproduction Facility (WRAIR, Army), and currently the Associate Director of Manufacturing/Product Development at Altimmune, Inc.

Daniel Douek – Chief of the Human Immunology Section at the NIH Vaccine Research Center, where the vaccine produced by Moderna was designed. Daniel plays a critical role in NIH’s COVID-related activities.

Ryan Spiegel – Gaithersburg City Councilmember, immediate past president of the Maryland Municipal League, and experienced government contracts attorney, has helped lead Gaithersburg and Maryland’s 156 other cities and towns in developing local government policies, programs, and communications and advocacy strategies responding to the public health, fiscal, and other community impacts of COVID-19.

We look forward to seeing you for this important discussion!